In Brief: FDA's National Mammography Quality Assurance Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
FDA's National Mammography Quality Assurance Advisory Committee: Meeting July 10, 11 and 12 at the DoubleTree Hotel in Rockville, Maryland. On July 10, "the committee will hear updates on approvals for alternative standards under the Mammography Quality Standards Act (MQSA) of 1992," according to the June 24 Federal Register. On July 10 and 11 the committee will discuss digital mammography under the MQSA. On July 12 the committee will discuss the issue of states as certifying bodies as well as the ongoing work of subcommittee. For more information, contact FDA's Charles Showalter, 301/594-3332...
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.